anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 22,891-22,920
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

22,891-22,920 of 26,550

filter-aware
06
The slide uses a combination of clinical data points and qualitative stakeholder feedback to establish the problem.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Data compares all psychiatric providers vs interventional psychiatric providers across two survey questions.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a visual metaphor of a cluttered, anxious mind alongside a list of clinical and economic impacts.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Agitate1 hit
12
Includes a large callout for the primary prevalence statistic and a list of clinical/economic impacts.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Agitate1 hit
14
Includes clinical trial data references and definitions for CGI-S and HAM-A.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Evidence & Proof1 hit
15
The slide presents two line charts comparing MM120 (100 µg) against placebo across two primary clinical endpoints.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Evidence & Proof1 hit
16
The slide uses a line chart to show longitudinal symptom reduction and a bar chart to show categorical outcomes (responders/remitters).MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Evidence & Proof1 hit
21
Uses a screenshot of a news article as evidence of failure.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
22
Uses a red arrow annotation to emphasize the gap between projected 2030 sales and the blockbuster threshold.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
23
The slide uses a visual gap analysis to highlight the shortfall against a market benchmark.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
24
The slide uses a highlighted excerpt from a third-party report to undermine the company's R&D track record.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
25
The slide uses a screenshot of a press release to validate the claim of continued product success.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
26
The slide uses analyst quotes to build a case for competitive pressure on Pfizer's core product.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
27
The slide uses a direct quote from a press release to highlight a clinical trial failure.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
28
The slide uses a primary source excerpt to establish the clinical efficacy and subsequent commercial success of the drug.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
29
The slide uses a screenshot of a news article as evidence.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
30
The slide highlights a contradiction between the CEO's stated focus on innovation and the market's focus on shareholder return.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
61
Starboard Value | Activist Presentation Deck | 74 slidesStarboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
62
The slide uses highlighting to emphasize key phrases in the CEO's quote regarding TSR and innovation.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
63
The chart uses a red vertical arrow to explicitly quantify the 132-point gap between the S&P 500 and Pfizer.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
64
The slide uses a competitor's own slide to demonstrate failure to meet stated objectives.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
65
Starboard Value | Activist Presentation Deck | 74 slidesStarboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
66
The chart uses a broken axis for the top two performers (NVO, LLY) to accommodate the scale.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
67
Uses a simple division framework to highlight capital allocation inefficiency.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
68
The slide uses a waterfall chart to critique capital allocation efficiency.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
69
Uses a 'bridge' style calculation to derive an incremental revenue requirement.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
70
The chart uses a standard waterfall bridge format to show the impact of LOEs and growth on 2030 revenue projections.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
71
Uses a simple causal chain diagram to link the target return to financial outcomes.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
72
Starboard Value | Activist Presentation Deck | 74 slidesStarboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
73
The chart includes a specific callout for 'PFE (Median R&D Efficiency)' at the end, suggesting a comparison of valuation vs. efficiency.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit